The impact of hypoxemia on nephropathy in extremely obese patients with type 2 diabetes mellitus

Journal of Clinical Sleep Medicine

Volumn 10, Issue 7, 2014, Pages 773-778

  Leong, Wen Bun ^a,b   Nolen, Melissa ^b   Thomas, G Neil ^a,c   Adab, Paymanè ^a   Banerjee, Dev ^d,e   Taheri, Shahrad ^f,g,h  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes mellitus; Diabetes nephropathy; Extreme obesity; Obstructive sleep apnea; Sleep disordered breathing

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN SATURATION; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP DISORDERED BREATHING; ANOXIA; DIABETES MELLITUS, TYPE 2; ENGLAND; MIDDLE AGED; OBESITY, MORBID; POLYSOMNOGRAPHY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; SLEEP APNEA, OBSTRUCTIVE;

ANOXIA; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; POLYSOMNOGRAPHY; RENAL INSUFFICIENCY, CHRONIC; SLEEP APNEA, OBSTRUCTIVE;

EID: 84904462913     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.3870     Document Type: Article

References (28)

1. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76. (Pubitemid 40095801)
2. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32. (Pubitemid 35463925)
3. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590-5. (Pubitemid 43076551)
4. Banerjee D, Leong WB, Arora T, et al. The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia. PLoS One 2013;8:e79521.
5. Pallayova M, Banerjee D, Taheri S. Novel insights into metabolic sequelae of obstructive sleep apnoea: A link between hypoxic stress and chronic diabetes complications. Diabetes Res Clin Pract 2014;104:197-205.
6. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. London: Royal College of Physicians, 2008.
7. National Kidney F K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
8. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
9. Iber C, Ancoli-Israel S, Chesson A Jr., Quan S. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine, 2007.
10. Sulit L, Storfer-Isser A, Kirchner HL, Redline S. Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 2006;29:777-83. (Pubitemid 43895046)
11. Furukawa S, Saito I, Yamamoto S, et al. Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus. Eur J Endocrinol 2013;169:239-46.
12. Schober AK, Neurath MF, Harsch IA. Prevalence of sleep apnoea in diabetic patients. Clin Respir J 2011;5:165-72.
13. Buyukaydin B, Akkoyunlu ME, Kazancioglu R, et al. The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2012;98:140-3.
14. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008;31:249-55. (Pubitemid 351461104)
15. Unruh ML, Sanders MH, Redline S, et al. Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol 2006;17:3503-9. (Pubitemid 44865293)
16. Sim JJ, Rasgon SA, Kujubu DA, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2009;135:710-6.
17. Ahmed SB, Ronksley PE, Hemmelgarn BR, et al. Nocturnal hypoxia and loss of kidney function. PloS One 2011;6:e19029.
18. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999;34:309-14. (Pubitemid 29409233)
19. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001;37:511-5. (Pubitemid 32199020)
20. Shikano M, Sobajima H, Yoshikawa H, et al. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 2000;85:81-5. (Pubitemid 30242834)
21. Fernandez-Real JM, Vendrell J, Garcia I, Ricart W, Valles M. Structural damage in diabetic nephropathy is associated with TNF-alpha system activity. Acta Diabetol 2012;49:301-5.
22. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-7. (Pubitemid 41532603)
23. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34. (Pubitemid 36297204)
24. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 2003;92:522-8. (Pubitemid 37013402)
25. Calabrese V, Mancuso C, Sapienza M, et al. Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 2007;12:299-306.
26. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008;117:2270-8.
27. Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ. Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 2005;28:1710-7. (Pubitemid 40923082)
28. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003;22:251-7. (Pubitemid 36986993)